Perspectives on neurologic involvement in COVID-19

Lives all over the world over are currently being impacted by coronavirus disease 2019 (COVID-19).1,2 The cause of COVID-19 is a novel coronavirus, severe acute respiratory distress coronavirus 2 (SARS-CoV-2), that first emerged in Wuhan, China in December 2019.2 Doctor Abdul Mannan Baig and his team have attempted to answer some of the pressing questions that neurologists and other healthcare professionals may have regarding the neurotropic potential of the SARS-CoV-2. The SARS-CoV-2 causes acute respiratory illness, typically manifesting as fever and cough or shortness of breath.2 Of particular interest is the characterization of neurologic symptoms and the query that whether there is a concurrent neurologic involvement contributing in the respiratory failure seen in COVID-19 cases.1